INS and type 1 diabetes mellitus: Of those who were currently using diabetes apps for their self-management, 120 (21.9%) of respondents with type 1 diabetes reported using their app for calculating insulin doses, of which 29 (25%) mentioned that they had erroneous results in calculating insulin doses with these apps.